ADVANCES IN THE DIAGNOSIS AND TREATMENT OF THE RHEUMATIC DISEASES
Date Held:
May 15th & 16th, 2009
In its fifth year, this two-day symposium was held for the providers of care to patients with rheumatic diseases. Given the wide variety of rheumatologic disorders, and an ever-increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Who Should Attend
This activity is intended for rheumatologists, internists, gerontologists, orthopedic surgeons and other allied health professionals.
Objectives
Following this activity, the participant will demonstrate the ability to:
- Discuss recent advances in the use of biologic agents in the treatment of rheumatoid arthritis
- Appreciate the unique challenges associated with transitioning the pediatric rheumatic disease patient into adult practice
- Discuss new and emerging issues in the management of gout
- Recognize the major issues related to the management of the pregnant rheumatic disease patient
- Recognize the major ophthalmologic manifestations of the rheumatic diseases
- Diagnose and manage common pulmonary manifestations of the rheumatic diseases
- Discuss current management approaches and controversies in the diagnosis and treatment of giant cell arteritis
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Policy on Speaker and Provider Disclosure
It is the policy of The Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.
Acknowledgement
Applications for commercial support from health care related industries are pending. A complete list of contributors will be provided in the syllabus.
